AF
MXCT icon

Allworth Financial’s MaxCyte MXCT Stock Holding History

Allworth Financial’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61K Buy
4,558
+3,235
+245% +$3.22K ﹤0.01% 4060
2026
Q1 		$930 Buy
+1,323
New +$1.24K ﹤0.01% 4591
2025
Q3 		– Sell
-71
Closed -$155 – 4996
2025
Q2 		$155 Buy
+71
New +$172 ﹤0.01% 4350

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Allworth Financial's MXCT Position: Q2 2026 in Review

Allworth Financial increased its MaxCyte (MXCT) stake by 245% in Q2 2026, buying an estimated $3.22K and bringing the position to 4,558 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #4060.

Allworth Financial first reported a position in MXCT in Q2 2025 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Allworth Financial held 4,558 shares of MaxCyte worth $5.61K as of Q2 2026.
  • Allworth Financial bought 3,235 MaxCyte shares in Q2 2026, an estimated $3.22K.
  • MaxCyte made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4060 holding.
  • Allworth Financial first reported a position in MaxCyte in Q2 2025 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.